Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents

By  

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1189-1212

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

By Long B.H.   Balasubramanian B.N.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 635-666

Informa Healthcare

Access to resources Recommend Favorite

In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-10 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes

By  

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1928-1939

Bentham Science Publishers

Access to resources Recommend Favorite